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Background
The waiting room in psychiatric services can provide an ideal
setting for offering evidence-based psychological interventions
that can be delivered through electronic media. Currently, there
is no intervention available that have been developed or tested in
mental health.
Aims
This proof-of-concept study aimed to evaluate a pilot design of
RESOLVE (Relaxation Exercise, SOLving problem and cognitiVe
Errors) to test the procedure and obtain outcome data to inform
future, definitive trials (trial registration at Clinicaltrials.gov
NCT02536924, REB Number: PSIY-477-15).
Method
Forty participants were enrolled and equally randomised to the
intervention, RESOLVE plus treatment as usual arm (TAU), or to a
control group (TAU only). Those in the intervention group
watched RESOLVE in a room adjacent to the waiting area.
Participants in the control received routine care. Outcome
measures included the Hospital Anxiety and Depression Scale;
the Clinical Outcomes in Routine Evaluations outcome measure;
and the World Health Organization Disability Assessment
Schedule. These measures were performed by a masked
assessor at baseline and at 6-week follow-up. Additionally, we
measured the number of contacts with mental health services
during the prior 4 weeks. Both intention-to-treat and per protocol
analyses were performed.
Results
The study proved feasible. We were able to recruit the required
number of participants. There was a statistically significant
improvement in depression (P < 0.001), anxiety (P < 0.001), general
psychopathology (P < 0.001) and disability (P = 0.0361) in favour of
the intervention group. People in the intervention group were less
likely to contact the service (P = 0.012) post-intervention.
Conclusions
Findings provide preliminary evidence that evidence-based
psychosocial interventions can be delivered through electronic
media in a waiting-room setting. The outcome data from this
study will be used for future definitive trials.
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Background
The healthcare waiting-room setting presents an opportunity to
offer a variety of interventions to patients. The average amount of
time people spend in a physician’s waiting room varies between
19 and 50 min.1,2 Sherwin et al suggest that waiting rooms can be
used for a variety of interventions, for example to complete vali-
dated questionnaires, question prompt sheets or brief training,
and provide patient education material and decision aids.3
Only limited literature is available on the use and evaluation of
specific interventions developed for waiting rooms. Few studies
have assessed the impact of interventions provided in the waiting
room. These studies aremostly limited to health education delivered
in a variety of formats, ranging from pamphlets to audiovisual aids
and in a variety of healthcare settings.4–10
Evidence suggests that single-session interventions can be
effective in managing a variety of mental and emotional health pro-
blems.11–17 There is also evidence that a brief video intervention
might help with mental health problems.18 Therefore, we believe
that waiting-room interventions for psychiatric settings can go
beyond simple educational material and psychiatric interventions
can be offered through digital media, including audiovisual
material.
We performed a literature search to identify studies of waiting-
room interventions in mental health. We did not find a published
report on the development or evaluation of a waiting-room inter-
vention explicitly developed for psychiatric patients. We developed
a waiting room video intervention, RESOLVE (Relaxation Exercise,
SOLving problem and cognitiVe Errors), for the psychiatric waiting
room. This paper reports the results of a proof-of-concept study that
evaluated the intervention in a crisis clinic.
Development of RESOLVE
RESOLVE was developed following clinical observations by us,
informal discussions with clinical colleagues and experts in the
field. Clinical observations suggest that employing relaxation strat-
egies, analysing the problem and better understanding our thought
processes are useful first steps towards feeling better. We decided to
focus on problem-solving therapy (PST) as this approach can be
taught using electronic media. A video was produced based on
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this problem-solving approach. PST is effective for a variety of
mental health problems.19,20 People in distress often have difficul-
ties thinking clearly about their situation and what might help to
improve it and a problem-solving approach may be useful in
helping people presenting to crisis or emergency services.21 One
reason for people to seek help from psychiatric crisis services is
that their ability to cope and solve problems on their own has
been insufficient.22 Mindfulness-based breathing exercises have
also been found to be useful in helping those withmental health pro-
blems.23 There is sufficient evidence to suggest a role for breathing
exercises in dealing with stress, anxiety and negative affect.24
According to cognitive theory, our dysfunctional thoughts lead to
extreme emotions.25 Fu et al (2013)16 reported that a single
session of cognitive bias modification training could reduce negative
interpretations in adolescents with anxiety disorders. Hence, a brief
introduction to common cognitive errors was considered of poten-
tial use.
We developed a video containing information on breathing
exercises, information about cognitive errors and problem-solving
skills. The video can be delivered using electronic media (for
example on a television screen) in waiting rooms. The video starts
with an explanation of breathing exercises, with an explanation of
the fight and flight centre and how the centre is activated during
stress, and explaining the breathing method in detail. The major
part of the video revolves around a fictional character who uses
steps in solving a problem to sort out a financial problem. These
steps include defining the problems, making a list of problems,
choosing the right solution and acting on it in small steps. Finally,
the narrator explains common cognitive errors, each with an
image and an example. This intervention is only 8 min 38 s long
and can be shown while patients are in a waiting room in a psychi-
atric crisis clinic. It can be accessed at: (https://www.youtube.com/
watch?v=53BA7l3v6ZA&t=53s).
Treatment as usual
All study participants received treatment as usual (TAU), which
mainly consisted of weekly or biweekly contacts with a caseworker
who usually worked with the clients to monitor mental state, ensure
medication adherence, help with practical issues such as housing,
etc. Social workers and psychiatrist also supported clients.
Method
Objectives
The objectives of the study were to test the trial procedure and
obtain outcome data to inform future definitive trials.
Study design and setting
This proof-of-concept study used a randomised, single-blind, con-
trolled trial design (trial registration at Clinicaltrials.gov
Randomised and completed
baseline assessment
(n = 40)
Enrolment
Allocation
Follow-up
assessments
Fulfilled inclusion criteria (n = 44)
Not interested in participating (n = 20)
Potential participants identified by workers
 (n = 74)
Expressed interest
 (n = 54)
Failed inclusion criteria (n = 6)
Refused to participate (n = 4) 
Refused to consent (n = 4)
Allocated to control group
(n = 20)
Allocated to intervention
group (n = 20)
Completed (n = 16)
Non-completers (n = 4)
(Refused to reply 1
Moved to another city 3)
Completed (n = 17)
Non completers (n = 3)
(Moved to another city 1
Refused to reply 1
Returned to full-time
work 1)
Fig. 1 Consort flow diagram of the trial.
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NCT02536924, REB Number: PSIY-477-15). It was conducted from
January 2016 to January 2017. The local institutional review board
at Queens University, Kingston, Canada, approved the trial proto-
col. After a full description of the study, all participants provided
written informed consent before entering the study. The interven-
tion group received RESOLVE and TAU, and the control group
received TAU.
Inclusions and exclusion criteria
Individuals were included if they were ≥18 years, were attending
crisis service for the first time and had a diagnosis of a mood or
anxiety disorder according to the DSM-IV.26 Individuals with sub-
stance dependence, active psychosis, organic brain syndrome or
intellectual disability, as well as those with high levels of disturbed
behaviour, were excluded.
Participants
Participants were recruited for the study during their visit to the
crisis team walk-in services in Kingston, Ontario, Canada.
Following their appointment with a crisis worker, participants
were asked by their worker if they would like to participate in a
research project. A member of the research team then contacted
those considered suitable and invited them to participate in the
study. Consenting participants were randomly allocated to inter-
vention or control in a 1:1 ratio.
We enrolled 40 individuals, assigned randomly to the interven-
tion group (n = 20) or the control group (n = 20). Three individuals
from the intervention and four from the control group were not
contactable for final assessment (see Fig. 1).
Procedures
Clinical staff identified 74 individuals who could potentially meet
the inclusion criteria for the study. Research staff contacted this
group, and 54 expressed interest in participating in the study. Out
of 44 individuals considered suitable after the initial assessment,
40 individuals consented to and participated in the study (Fig. 1).
Participants in the intervention arm were invited to watch the
video in one of the assessment rooms adjacent to the waiting
room. They were then given a copy of the video and handouts on
problem-solving, relaxation and cognitive errors. Those in the
control arm were offered only routine care.
Individuals who met inclusion criteria were randomly assigned to
either the intervention (n = 20) or control (n = 20) only. Randomisation
was performed using computer-generated numbers from a website
(www.randomization.com). Block randomisation with randomly per-
muted block size was used to ensure similar numbers of participants
were allocated to each arm of the trial. Individuals were assigned to
either intervention or the control arm by the research team members
who were independent of the assessment team.
Outcome measures
Outcome assessments were carried out by raters who were inde-
pendent of those providing the intervention and masked to the
intervention allocation and adherence. At the 6-week follow-up,
participants had the option of completing the assessments in
person or over the phone.
The following assessments were performed at baseline and
6 weeks; the Hospital Anxiety and Depression Scale (HADS),25
the Clinical Outcomes in Routine Evaluations (CORE) outcome
measure,28 the World Health Organization Disability Assessment
Schedule (WHO-DAS) 2.027 and documentation of the number of
contacts with the mental health services during the prior 4 weeks.
The CORE was used to capture a broader range of symptoms and
to see whether the change in psychopathology went above and
beyond the anxiety and depressive symptoms. Finally, we decided
to measure the change in disability to find out whether symptomatic
change, if any, accompanied improvement in functioning or not.
We also wanted to see whether this intervention will reduce the fre-
quency of contacts with the service and therefore looked into this
variable independently.
The HADS27 is a 14 item, self-assessment scale designed to
measure anxiety and depression. It has high internal consistency,
face validity and concurrent validity. Even numbered questions
relate to depression and odd numbered questions relate to
anxiety. Each question has four possible responses. Responses are
scored on a scale from 0 to 3. The maximum score is 21 for depres-
sion and 21 for anxiety. A score of 11 or higher indicates the prob-
able presence of depression, whereas a score of 8 to 10 is suggestive
of the presence of the respective state. In its current form the HADS
is now divided into three ranges: normal (0–7), borderline abnormal
(8–10), ‘cases’ (11–21).
The brief WHO-DAS 2.028 is a 12-item self-report question-
naire that assesses disability and functioning in the prior month.
The WHO-DAS 2.0 was developed to assess six different adult
life tasks: (a) understanding and communication; (b) self-care;
(c) mobility (getting around); (d) interpersonal relationships (getting
along with others); (e) work and household roles (life activities);
and (f) community and civic roles (participation).
The CORE outcome measure29 is a self-report questionnaire
that asks 34 questions about how a person has been feeling over
the past week. It uses a five-point scale ranging from ‘not at all’ to
‘most or all of the time’. The 34 items of the measure cover four
dimensions: subjective well-being, problems/symptoms, life func-
tioning, risk/harm.
The sample size
This is a proof-of-concept study using an randomised control trial
design. Therefore, no power calculation was conducted. The
results of this proof-of-concept study will be used to calculate
sample sizes for future larger randomised controlled trials. It has
been suggested that a sample size of 12 in each arm should suffice
for pilot studies.30 Allowing for up to 40% drop-out, we, therefore,
recruited 40 participants for the study, including 20 participants per
arm.
Statistical analyses
The analyses were carried out using SPSS v24. A descriptive analysis
of the randomisation groups relative to its baseline characteristics
was conducted where means and standard deviations were calcu-
lated for continuous variables and proportions for categorical vari-
ables. Because of the small sample sizes, group comparison at
baseline was conducted using Fisher’s exact test for categorical vari-
ables and the Mann–Whitney U-test for continuous variables. Our
main analysis compared the outcomes at 6 weeks using the
ANCOVA approach where the outcome at week 6 is specified as
the dependent variable, and the treatment group along with baseline
value of the outcome are specified as predictors. As this is a proof-
of-concept study, we have not adjusted P-values for multiple com-
parisons and used only data for completers in our main analysis.
A sensitivity analysis that imputed outcomes using last-observa-
tion-carried-forward (LOCF) obtained almost identical results. In
our case, we consider the LOCF approach conservative as most par-
ticipants were observed to improve over time and LOCF necessarily
forces the outcome to be stable over time. For practical interpret-
ation, we also report raw Cohen’s d effect sizes.
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Results
Participants had a mean age of 30.3 years (range 20–52), with an
almost equal gender ratio with 53% women (n = 21). They had a
mean of 2.45 (range 0–10) past admissions in a psychiatric facility.
Most clients were ethnically White (n = 32, 80%), were single (n =
21, 52.5%) and had college education (n = 26, 65%). In terms of
diagnoses, 30.0% (n = 12) had depression, 10.0% (n = 4) had gener-
alised anxiety disorder, 12.5% (n = 5) had post-traumatic stress dis-
order, 25% (n = 10) had mixed anxiety and depression, 2.5% (n = 1)
had a personality disorder, 7.5% (n = 3) had an anxiety disorder,
7.5% (n = 3) had an adjustment disorder and 5% (n = 2) had more
than one diagnosis.
At baseline 40.0% (n = 16) were using antidepressants.
Percentages for other baseline medications were 2.5% (n = 1) anxio-
lytics, 2.5% (n = 1) antipsychotics, 35.0% (n = 14) mood stabilisers
and 20.0% (n = 8) were on multiple medication. Baseline demo-
graphics and clinical characteristics of the individuals in the inter-
vention and control groups are shown in Table 1. There were no
statistical differences in any baseline values between the two groups.
Table 2 shows the results of the ANCOVA. Both the differences
at the end of the intervention period and differences controlled for
baseline are described. The participants in the treatment group
showed significantly greater improvements on total HADS score
(P < 0.001), anxiety subscale of HADS (P < 0.001), depression sub-
scale of HADS (P≤ 0.001), CORE (P≤ 0.001) and disability (P =
0.036) from baseline compared with the participants in the control
group at the end of the study period. Participants in the intervention
group also made fewer contacts with the mental health professionals
during the past 4 weeks at the end of the study period (intervention,
median 1.0 (interquartile range (IQR) = 3.0), control mean 4.0
(IQR = 2.0), P<0.001) as per the electronic health record system.
We performed a sensitivity analysis for each outcome with
missing values at the end of the trial imputed using the LOCF
method. Results are shown in Table 3. None of the conclusions
mentioned previous changed.
Discussion
To the best of our knowledge, this is the first report of the develop-
ment and pilot testing of an intervention using a waiting-room
setting and based on an evidence-based therapy for common
mental disorders. Those receiving the intervention showed
improvement in depression, anxiety, general psychopathology and
disability. These participants were also less likely to seek profes-
sional help compared with those in the control group. This has
potential implications for healthcare costs. These initial results are
encouraging and provide new opportunities for providing brief psy-
chosocial interventions to people in a waiting room. Although we
tested the intervention in a crisis clinic setting, it has the potential
to be used in general psychiatric waiting rooms as well as in
general medical waiting rooms or primary care settings.
There is significant prior evidence for the effectiveness of PST,
mindfulness breathing and teaching cognitive errors for common
mental disorders. This report confirms prior studies that PST can
be effective for a variety of conditions, including psychiatric and
physical health problems.
This work is in line with past reports of the success of single-
session psychological interventions. One session of cognitive
behavioural therapy has been used to treat trauma12,13 anxiety for
depression,31 for medication adherence for depression,32 for
anxiety disorders,11,33,34 for pain catastrophizing35 and for addic-
tion problems.36 Similarly, a single session of motivational
interviewing has been shown to be effective for the treatment of
addiction as well as in treatment adherence.14,15,36 Single-session
interventions have also been tested and found to be effective using
virtual reality programs for anxiety disorders.17,37
We aimed to develop a similar intervention using a video and
the time spent in the waiting area. We found the intervention to
be useful for the management of psychological distress. This
might prove to be a cost-efficient way of delivering an intervention
that is likely to be useful for a variety of conditions including psychi-
atric and physical health conditions. The participants for this trial
were selected from a crisis team but the intervention could also be
used in other settings such as waiting rooms for community
mental health teams or primary care.
Table 1 Differences in demographic variables and psychopathology
between the intervention and the control groups at baseline
Intervention
(n = 20)
Control (TAU)
(n = 20) Pa
Age, mean (s.d.) 28.8 (10.7) 31.2 (9.4) <0.081
Past history of psychiatric
admissions, mean (s.d.)
2.60 (2.21) 2.30 (3.1) <0.461
Gender, n (%)
Men 9 (45) 10 (50) <1.000
Women 11 (55) 10 (50)
Ethnicity, n (%)
White 16 (80) 16 (80) <1.000
Black and minority ethnic 4 (20) 4 (20)
Marital status, n (%)
Married or in a partnership 7 (35) 12 (60) <0.205
Single 13 (65) 8 (40)
Education, n (%)
High school 1 (5) 4 (20) <0.421
College 14 (70) 12 (60)
Graduates or above 5 (25) 4 (20)
Past drug/alcohol use, n (%)
Recreational 9 (45) 5 (25) <0.076
Misuse 1 (5) 2 (10)
Dependence 1 (5) 7 (35)
None 9 (45) 6 (30)
Employment, n (%)
Unemployed 8 (40) 13 (65) <0.205
Employed 12 (60) 7 (35)
Diagnoses, n (%)
Depression 7 (35) 5 (25) <0.445
Generalised anxiety disorder 2 (10) 2 (10)
Post-traumatic stress disorder 4 (20) 1 (5)
Mixed anxiety and depression 3 (15) 7 (35)
Personality disorder 0 (0) 1 (5)
Anxiety disorder 2 (10) 1 (5)
Adjustment disorder 2 (10) 1 (5)
More than one diagnoses 0 (0) 2 (10)
Family history,b n (%)
Yes 14 (70) 12 (60) <0.741
No 6 (30) 8 (40)
Medication, n (%)
Antidepressants 9 (45) 7 (35) <0.644
Anxiolytics 0 (0) 1 (5)
Antipsychotics 0 (0) 1 (5)
Mood stabilisers 6 (30) 8 (40)
Multiple medication 5 (25) 3 (15)
HADS Anxiety, mean (s.d.) 11.25 (1.74) 10.75 (3.04) <0.512
HADS Depression, mean (s.d.) 10.10 (1.74) 9.25 (2.22) <0.289
HADS Total, mean (s.d.) 21.35 (2.41) 20 (4.5) <0.414
CORE, mean (s.d.) 74.25 (19.81) 69.45 (21.60) <0.355
WHO-DAS, mean (s.d.) 23.05 (6.40) 21.45 (5.28) <0.341
TAU, treatment as usual; HADS, Hospital Anxiety and Depression Scale; CORE, Clinical
Outcomes in Routine Evaluations outcome measure; WHO-DAS, World Health
Organization Disability Assessment Schedule 2.0.
a. P-values were calculated using non-parametric Mann–Whitney U-test for continuous
variables (age and clinical matrices) and Fisher’s exact test for the rest of variables that
were categorical.
b. Family history of any psychiatric diagnosis.
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We believe that the waiting room could offer a suitable venue for
providing psychosocial interventions. Patients spend a varying
amount of time in waiting areas before healthcare professionals
see them. This is the time when patients may be more receptive,
and an intervention can not only help overcome anxiety in the
waiting room but also can have a long-term beneficial effect. This
may explain the significant effect of the intervention on depressive
and anxiety symptoms
Limitations
Limitations include the small sample size and a short follow-up
period. As such, more data is warranted to confirm these results.
Participants in the intervention arm were invited individually to a
small room adjacent to the waiting room to watch the video. In
real life, not all those sitting in the waiting room might be receptive
to the intervention. It is of note that the effect sizes were larger for
psychopathology than disability. We also recognise that the large
effect sizes might be because of the small sample size. Although
this is a small study, future enhancements in the intervention
could include behavioural activation to improve functional out-
comes. Future studies need to include those with severe mental
illness, and issues with substance misuse – the intervention in its
current form was only tested with people with more common
mental disorders. Similarly, the intervention was tested in a crisis
clinic, although we believe it can be easily used in other medical
and psychiatric settings.
Implications
Patients spend a significant amount of their time in psychiatric
waiting rooms. This study confirms past reports of the efficacy of a
single-session psychosocial intervention. However, the intervention
in this group was delivered through a video instead of a therapist.
In this proof-of-concept study, we found that evidence-based inter-
ventions could be delivered through electronic media to a group of
patients in the waiting room of a crisis team.We found that the inter-
vention was acceptable and significantly improved anxiety and
depressive symptoms. Further research is required to validate these
findings with adequately powered trials with better methodology.
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Table 2 Differences between the treatment and control groups, both uncontrolled and controlled for baseline differences
Post-trial unadjusted group
means (s.d.) post trial Mean differences adjusted for baseline outcome
Intervention
(n = 17)
TAU
(n = 16)
Mean difference between
groups post trial (95% CI) Partial η2 (numDF, denDF) F Cohen’s da Pb
HADS Anxiety 5.3 (1.7) 8.4 (2.6) −3.6 (−4.7 to −2.5) 0.60 (1.30) 45.2 1.65 <0.001
HADS Depression 3.9 (2.2) 7.0 (2.1) −3.8 (−5.0 to −2.6) 0.57 (1.30) 40.3 1.77 <0.001
HADS Total 9.2 (3.7) 15.4 (4.2) −7.5 (−9.7 to −5.2) 0.51 (1.30) 46.4 1.90 <0.001
CORE 31.1 (20.7) 57.3 (18.9) −25.3 (−39.8 to −10.7) 0.29 (1.30) 12.5 1.27 0.001
WHO-DAS 2.0 11.8 (8.7) 19.7 (11.3) −7.9 (−15.3 to −0.5) 0.14 (1.30) 4.8 0.80 0.036
TAU, treatment as usual; numDF, numerators for degrees of freedom; denDF, denominators for degrees of freedom; HADS, Hospital Anxiety and Depression Scale; CORE, Clinical Outcomes
in Routine Evaluations outcome measure; WHO-DAS, World Health Organization Disability Assessment Schedule 2.0.
a. Cohen’s d was calculated by dividing the adjusted difference at the end of the trial by the pooled SD at baseline.
b. P-values calculated using ANCOVA, controlling for baseline value of the outcome.
Table 3 Sensitivity analysisa
Post-trial unadjusted group
mean (s.d.) Mean differences adjusted for baseline outcome
Intervention (n = 20) TAU (n = 20)
Mean difference
between groups at
post trial (95% CI) Partial η2 (numDF, denDF) F Cohen’s db Pc
HADS Anxiety 6.1 (2.6) 8.9 (2.6) −2.9 (−4.5 to −1.40) 0.29 (1.37) 14.8 1.12 <0.001
HADS Depression 4.8 (2.9) 7.4 (2.0) −3.1 (−4.6 to −1.6) 0.32 (1.37) 17.9 1.24 <0.001
HADS Total 11.0 (5.5) 16.3 (4.1) −6.0 (−9.0 to −2.0) 0.30 (1.37) 16.5 1.24 <0.001
CORE 37.5 (24.7) 59.6 (17.4) −21.6 (−35.5 to −7.7) 0.21 (1.37) 9.9 1.01 0.003
WHO-DAS 2.0 13.5 (8.9) 19.9 (10.0) −6.6 (−12.8 to −0.4) 0.11 (1.37) 4.6 0.70 0.038
TAU, treatment as usual; numDF, numerators for degrees of freedom; denDF, denominators for degrees of freedom; HADS, Hospital Anxiety and Depression Scale; CORE, Clinical Outcomes
in Routine Evaluations outcome measure; WHO-DAS, World Health Organization Disability Assessment Schedule 2.0.
a. Last-observation carried-forward was used to impute missing values for the seven patients who dropped out. Differences between the treatment and control groups, both uncontrolled
and controlled for baseline differences. Analyses were carried out using an ANCOVA.
b. Cohen’s d was calculated by dividing the adjusted difference at end of trial by the pooled standard deviation at baseline.
c. P-values calculated using ANCOVA, controlling for baseline value of the outcome.
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